期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Novel technique for craniospinal radiotherapy with patient supine 被引量:3
1
作者 李兵 鹿红 +2 位作者 罗立民 沈傲东 沈君姝 《Journal of Southeast University(English Edition)》 EI CAS 2009年第3期326-329,共4页
A simple procedure to plan, verify and implement craniospinal irradiation(CSI) with patients supine is presented. Treatment is conducted with a single posterior spinal field abutting two lateral cranial fields. The ... A simple procedure to plan, verify and implement craniospinal irradiation(CSI) with patients supine is presented. Treatment is conducted with a single posterior spinal field abutting two lateral cranial fields. The opposed lateral fields are half-blocked and the inferior line is perpendicular. The posterior field uses some fixed field parameters so that the cephalad edge of the posterior field is coplanar with the caudal edges of the lateral fields and it is independent of the height of the couch. A steel-shot ball is used to measure the size of overlap or gap at the junction using portal images of an electron portal image device or portal films. The results of analyzing the portal images show that the errors of the junction are within ± 1 mm. The dose-volume histograms (DVHs)show that there are not unbearable hot or cold spots in the clinic target volumes (CTVs). Supine craniospinal treatment is a reliable and convenient alternative to treatment in the prone position and avoids the technical difficulties of the latter. The use of fixed field geometry greatly facilitates treatment planning and effectively reduces the amount of time of setup, verification and treatment. 展开更多
关键词 craniospinal radiotherapy supine position SETUP VERIFICATION treatment
下载PDF
Recombinant human vascular endostatin injection to synchronize craniospinal radiotherapy for the treatment of recurrent medulloblastoma in children:A retrospective clinical study
2
作者 Yang Song He Xiao +3 位作者 Chuan Chen Ping Liang Wenyuan Ji Mingying Geng 《Oncology and Translational Medicine》 CAS 2021年第3期115-122,共8页
Objective Medulloblastoma(MB)is the most common primary central nervous system malignancy in children.Nonetheless,there is no standard treatment for recurrent MB.The purpose of this study was to investigate the clinic... Objective Medulloblastoma(MB)is the most common primary central nervous system malignancy in children.Nonetheless,there is no standard treatment for recurrent MB.The purpose of this study was to investigate the clinical value and toxicity of recombinant human endostatin injection(Endostar~?)combined with craniospinal radiotherapy for the treatment of recurrent MB in children.Methods This study retrospectively analyzed 13 patients with recurrent MB aged 5–18 years.Endostar?7.5 mg/m~2/d was synchronized during craniospinal radiotherapy for 7 children with a portable micro uniform speed infusion pump.Endostar~?was applied 3 days prior to the initiation of radiotherapy.The drug was in continuous use for 7 days.Similarly,the withdrawal of the drug took place over 7 days.This represented a cycle.During radiotherapy,the application was repeated until the end of radiotherapy(experimental group).In the other 6 cases,only craniospinal radiotherapy was used(control group).Results The complete remission rate was 71.4%in the experimental group and 16.7%in the control group.The median progression-free survival(PFS)was 14 months(95%CI:0.0–29.60)and 19 months(95%CI:0.0–39.53)in the experimental and control groups,respectively.The median overall survival(OS)was 19 months(95%CI:0.0–38.20)and 23 months(95%CI:2.47–43.53)in the experimental and control groups,respectively.The most common adverse events included grade 1 thrombocytopenia(7.7%),grade 3 neutropenia(38.5%),and grade 1 anemia(30.8%).Conclusion Endostar~?synchronizing craniospinal radiotherapy significantly improved the complete response rate of children with recurrent MB.It did not increase the side effects of radiation therapy.However,it did not improve the PFS or OS. 展开更多
关键词 recombinant human vascular endostatin craniospinal radiotherapy MEDULLOBLASTOMA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部